Fernando Pacheco
Partner
Fernando is a Partner at Endeavour Vision, leading investments across a range of therapeutic areas. Fernando has joined Endeavour in 2018, he brings 15 years of medtech experience spanning industry, strategy consulting and venture investing.
He led investments in Miach Orthopaedics and Virtual Incision, co-led CeQur, and serves as a board director at all three. He was a board observer at SOPHiA GENETICS (NASDAQ: SOPH) ahead of its 2021 IPO.
Previously, Fernando was an Engagement Manager at McKinsey & Co, running strategy and organisational projects for medical device and pharmaceutical clients across Europe, the US and Brazil. Earlier, he was a project engineer at Stryker Trauma & Extremities, developing orthopaedic trauma implants.
Fernando holds an MEng in Biomedical Engineering from Imperial College London, including a year at ETH Zürich.